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Abstract
Slow wave (or stage N3) sleep has been linked to a variety of cognitive processes. However,
the role of stage N3 in the elderly is debated. The link between stage N3 and episodic mem-
ory may be weakened or changed in the older adult population, possibly due to several
altered mechanisms impacting the cellular structure of the brain. The bases for the age-
related dissociation between stage N3 and cognition are not understood. Since APOEε4
status is the strongest genetic risk factor for cognitive decline, we assessed whether the ε4
allele is associated with stage N3 sleep. Participants were from the population-based Osteo-
porotic Fractures in Men (MrOS) cohort with polysomnography and APOEε4 genotype data
(n = 2,302, 100% male, mean age 76.6 years). Sleep stages were objectively measured
using overnight in-home polysomnography and central electroencephalogram data were
used to score stage N3 sleep. Cognitive function was assessed using the Modified Mini
Mental State Exam (3MS). The APOE rs429358 single nucleotide polymorphism, which
defines the APOEε4 allele, was genotyped using a custom genotyping array. Total time in
stage N3 sleep was significantly higher (p<0.0001) among the 40 MrOS participants carry-
ing two copies of the ε4 allele (62±5.2 minutes) compared with 43±1.5 minutes for carriers of
one ε4 allele (n = 515) and 40±0.8 minutes for ε4 non-carriers (n = 1747). All results were
independent of sleep efficiency, number of sleep cycles, and apnea hypopnea index. These
findings support an association between APOEε4 genotype and sleep stage N3 in the
elderly. Increased total stage N3 duration among ε4/ε4 carriers does not appear to reflect
compensation for prior cognitive decline and may reflect overactive downscaling of
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synapses during sleep. If confirmed, these results might in part explain the high risk of age-
related cognitive decline and AD among APOE ε4/ε4 carriers.
Introduction
Sleep disturbances and specific sleep disorders increase with advancing age [1–6] and elevate
the risk for a variety of diseases and conditions [7–22] including cognitive impairment [23–
33]. Recent research indicates that sleep may specifically impact the cellular structure of the
brain, including the ability of the brain to clear toxic metabolites that accumulate with normal
neuronal function [34]. This includes beta-amyloid [34], which accumulates in apolipoprotein
E (APOE) ε4 genotype carriers [35] and contributes to synaptic degeneration and cognitive
decline. While the APOEε4 allele is a well-established risk factor for Alzheimer’s disease (AD)
and age-related cognitive decline [36–42] as well as a risk factor for sleep apnea [43–51],
APOEε4 has not been assessed in relation to sleep stage distributions. To explore the hypothe-
sis that APOEε4 influences sleep architecture, we examined the effect of the APOEε4 allele on
sleep stage distribution measured in a large, population-based cohort of elderly participants
with a focus on stage N3, which represents the synchronization of cortical EEG activity and
has been implicated in memory formation in young populations [52–57]. Given the high risk
of cognitive decline and AD among APOEε4 carriers, identifying a genetic link with stage N3
sleep could advance the development of new approaches for interventions to slow the decline
in cognitive function among ε4 allele carriers and that may also benefit the health and well-
being of the elderly.
Materials and methods
Participants
Data were collected from participants of the Osteoporotic Fractures in Men (MrOS) Study
which included participants who were at least 65 years old and excluded participants who
required assistance with ambulation or had undergone bilateral hip replacement. In the MrOS
study, 5994 older men were recruited from six geographical areas (Birmingham, AL; the
Monongahela Valley near Pittsburgh, PA; Minnaepolis, MN; Palo Alto, CA; San Diego, CA;
and Portland, OR) between 2000 and 2002. The MrOS Sleep Study, an ancillary study of the
parent MrOS cohort, was conducted between December 2003 and March 2005 and recruited
3135 MrOS participants (68%) for a comprehensive sleep assessment and assessment of circa-
dian gene polymorphisms. Of the 2,859 men who did not participate in this ancillary study,
344 died before the sleep visit, 36 had already stopped participating in the study, 332 were not
invited because recruitment goals had already been met, 150 were not eligible and 1,997
refused. Among the participants of the MrOS Sleep Study, 2480 self-identified white men who
had DNA extracted for genetic studies. Details regarding the studies have been published pre-
viously [58,59]. All data were collected with written informed consent as approved by the insti-
tutional review boards of the clinical sites (University of Alabama at Birmingham; University
of Minnesota; University of Pittsburgh; Stanford University; Oregon Health & Science Univer-
sity, and University of California, San Diego) and the coordinating center (University of Cali-
fornia, San Francisco). The Outcomes of Sleep Disorders in Older Men Study (MrOS Sleep
Study) [60], an ancillary study of the parent MrOS Study, enrolled 3,135 participants from
2003–2005. Of the 3135 enrolled participants, 2911 had usable PSG data and, of these, 2745
(94%) with evaluable sleep staging data. The Modified Mini Mental State Exam [61,62] (3MS),
APOE and slow wave sleep
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an expanded 100 point version of the original MMSE, was administered in MrOS at the base-
line and sleep exams (~3 years) [63]. The Pittsburgh Sleep Quality Index (PSQI) and Epworth
Sleepiness Scale (ESS) questionnaires were administered at the sleep exam.
Polysomnography
In-home, single night sleep studies using unattended polysomnography (PSG, Safiro, Compu-
medics, Inc., Melbourne, Australia) were performed as previously described [64,65]. The
recording montage consisted of C3/A2 and C4/A1 electroencephalograms, bilateral electrocu-
lograms, a bipolar submental electromyogram, thoracic and abdominal respiratory inductance
plethysmography, airflow (using nasal-oral thermocouple and nasal pressure cannula), finger
pulse oximetry, electrocardiogram, body position (mercury switch sensor), and bilateral leg
movements (piezoelectric sensors). Trained certified staff members performed home visits for
setup of the sleep study units. After sensors were placed and calibrated, signal quality and
impedance were checked, and sensors were repositioned as needed to improve signal quality,
replacing electrodes if impedances were elevated, using approaches similar to those in the
Sleep Health Heart Study [66]. After studies were downloaded, they were transferred to the
Case Western Reserve University Reading Center (Cleveland, OH) for centralized scoring of
sleep stages and sleep disorders by a trained technician using standard criteria [67,68]. Sleep
was staged in 30-sec scoring epochs and electroencephalogram data were used to score stage
N3 using the criteria of Rechtschaffen and Kales [67]. Total time (minutes) and percent time
[100(Number of minutes scored as stage 3–4)/(total sleep time)] in stage N3 were calculated
for these analyses. The apnea hypopnea index (AHI) was calculated as the total number of
apneas and hypopneas per hour of sleep (4% desaturation) [69]. Sleep cycles were defined
using a modified version of the rules detailed by Feinberg and Floyd [70]. A cycle was defined
as a period of at least 15 minutes of NREM sleep starting with stage N2 or N3 and terminated
by the end of a period of REM sleep lasting at least 5 minutes for all cycles except cycle 1, or a
period of wake or stage N1 lasting 15 minutes or longer. Two epochs of REM sleep separated
by no more than 15 minutes of NREM sleep or wake were merged into a single REM period.
Average absolute spectral power density in log10(uV^2/Hz) was calculated for each sleep cycle
for the following bands: Slow oscillation: 0.25–1 Hz, Delta: 1.25–4 Hz, Theta: 4.25–8 Hz,
Alpha: 8.25–12 Hz, Sigma: 12.25–15 Hz, and Beta: 15.25–20 Hz. There was excellent inter-
scorer reliability for the key sleep parameters, including stage N3 (ICCs >0.92). Several addi-
tional sleep parameters were scored, including: wake after sleep onset time and sleep
efficiency.
APOE genotyping
The APOE rs429358 SNP, which defines the APOEε4 allele, was genotyped using a custom Illu-
mina Golden Gate assay (Illumina, San Diego, CA, USA) that included 529 SNPs as previously
described [71]. All individuals in this study are of European ancestry and are unrelated. Of
2,745 MrOS participants with PSG, 2,302 were genotyped for the rs429358 C/T alleles, which
define APOEε4 status by the presence of the C allele. All participants in this analysis are of
European ancestry.
Statistical analyses
Associations between APOEε4 status and sleep staging were based on 2,302 MrOS participants
with both PSG and rs429358 genotype data. All PSG and cognition measures were treated as
continuous variables in analyses examining both additive and dominant genetic models to
examine APOEε4 associations for total time and percent time spent in stage N3. All regression
APOE and slow wave sleep
PLOS ONE | https://doi.org/10.1371/journal.pone.0191281 January 25, 2018 3 / 12
models were adjusted for age and clinic site with additional models including measures of
sleep duration (TST), quality (WASO time and sleep efficiency) and AHI. Cognitive function
change (~3 years) from the visit prior to sleep assessment was calculated and used to stratify
stage N3-cognition analyses into high and low decline groups. All analyses were analyzed
using SAS version 9.4 (SAS Institute Inc, Cary, NC).
Results
Differences in age, cognition, sleep performance and stage N3 across three APOEε4 categories
are shown in Table 1. Total stage N3 time was significantly higher among 40 MrOS partici-
pants carrying two copies of the ε4 allele (62±5.2 minutes) compared with 43±1.5 minutes for
carriers of one ε4 allele (n = 515) and 40±0.8 minutes for ε4 non-carriers (n = 1747). The
APOEε4 association with stage N3 time (p = 0.0002) was not altered by adjustment for 3MS
(p = 0.0001). We examined the APOEε4-stage N3 association among MrOS participants who
had experienced either2 point decline or <2 point decline (based on median change) from
the previous 3MS assessment to the 3MS measured at the sleep visit. Total stage N3 time was
significantly higher among participants carrying two copies of the ε4 allele when compared to
the other genotype categories in both the group with2 point 3MS decline (p<0.0001) and
the group with<2 point decline (p = 0.0002) and the test for interaction between APOE allele
and 3MS decline was not significant (p = 0.21). In addition, the APOEε4 association with 3MS
Table 1. Characteristics of MrOS participants with PSG sleep staging and APOE genotyping.
APOEε4 alleles
0 1 2 p-valuea p-valueb
n (%) 1747 (75.8) 515 (22.5) 40 (1.7)
mean (SE) mean (SE) mean (SE)
Age, y 76.6 (0.1) 76.5 (0.2) 75.6 (0.9) 0.48 0.13
3MS (0 to 100) 93.4 (0.1) 92.4 (0.2) 90.2 (0.8) < .0001 0.003
Change 3MSc -1.01 (0.1) -1.47 (0.2) -3.34 (0.7) 0.0025 0.0026
Time in stage N3 (min) 40 (0.8) 43 (1.5) 62 (5.2) < .0001 < .0001
Change 3MS -2 41 (1.0) 42 (1.8) 61 (7.4) 0.03 0.008
Change 3MS < -2 38 (1.4) 45 (2.5) 64 (7.5) 0.0005 0.002
Time in REM (min) 70 (0.7) 68 (1.2) 65 (4.5) 0.21 0.13
Time in stage N1 (min) 24 (0.3) 24 (0.6) 22 (2.1) 0.68 0.48
Sleep efficiency (%) 76 (0.3) 76 (0.5) 81 (1.9) 0.05 0.01
Wake after sleep onset (min) 115 (1.6) 116 (2.8) 86 (10) 0.02 0.005
Apnea hypopnea index (4% desat) 13 (0.3) 12 (0.6) 14 (2.1) 0.57 0.56
Number of sleep cycles 4.7 (0.03) 4.6 (0.1) 4.6 (0.2) 0.50 0.97
Spectral power density- SOsc (log10(uV^2/Hz))
d 1.9 (0.01) 1.9 (0.02) 2.0 (0.6) 0.15 0.06
Arousal index 24 (0.3) 23 (0.5) 24 (1.9) 0.10 0.93
PSQI 5.6 (0.1) 5.5 (0.1) 5.3 (0.5) 0.69 0.55
ESS 6.1 (0.1) 6.1 (0.2) 5.7 (0.6) 0.76 0.47
Hypnotics, n 38 10 0
Adjusted for age
a Linear p-value across three genotypes
b P-value comparing carriers of two ε4 alleles to all others
c Baseline to sleep visit ~ 3 years.
d Spectral power density of the C3-A2 EEG in the slow oscillation (0.25–1 Hz) band for the final sleep cycle.
PSQI = Pittsburgh Sleep Quality Index; ESS = Epworth Sleepiness Scale
https://doi.org/10.1371/journal.pone.0191281.t001
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(p<0.0001) was not altered by adjustment for stage N3 time (p<0.0001) and the test for inter-
action between APOEε4 and stage N3 time in the association with 3MS was statistically signifi-
cant (p = 0.006). The APOE ε4/ε4 genotype was associated with higher sleep efficiency and
lower WASO but not the PSQI or ESS assessments. Spectral power density of the C3-A2 EEG
in the slow oscillation (0.25–1 Hz) band was calculated for the final sleep cycle and did not dif-
fer among APOE alleles (Table 1). The total number of sleep cycles did not differ among APOE
alleles (Table 1). The APOE associations with total stage N3 time did not change after addi-
tional adjustment for sleep efficiency (ε4/ε4 = 59±5.2 minutes, p = 0.0003), wake after sleep
onset (ε4/ε4 = 60±5.2 minutes, p = 0.0002), number of sleep cycles (ε4/ε4 = 64±5.6 minutes,
p = 0.0001), or AHI (ε4/ε4 = 62±5.1 minutes, p<0.0001).
Discussion
In the present study of>2,300 older men, we confirmed a significant association between
APOEε4 status and lower cognitive function scores and unexpectedly found that APOEε4 was
associated with increased stage N3 duration. Average total stage N3 time was>50% longer
among elderly APOE ε4/ε4 carriers (those who at the highest risk of developing AD and age-
related cognitive decline [36–42]) when compared to those with one or no copies of the ε4
allele. While those with the APOE ε4/ε4 genotype had more stage N3 time, stage N3 was not
associated with cognitive decline in MrOS [72], even after adjustment for APOEε4 statusCon-
sistent with increased stage N3 time among ε4/ε4 genotype carriers, the APOE ε4/ε4 genotype
was also associated with higher sleep efficiency and decreased WASO, indicating overall less
arousability. This finding was unexpected but could reflect a compensatory mechanism
wherein the consolidation process is upregulated in reaction to declining cognition. In order
to test this possibility we examined the APOEε4-stage N3 association among APOE ε4/ε4 par-
ticipants who had experienced either high or low ~3-year decline from the previous 3MS
assessment. Total stage N3 time did not differ between participants who had experienced
either high or low declines suggesting that the longer stage N3 time among ε4/ε4 carriers is
not compensating for prior cognitive decline. It has been suggested that the negative correla-
tions previously observed between stage N3 and subsequent learning in older adults is unlikely
due to memory consolidation [73], and might be explained by another function of stage N3
such as synaptic downscaling or pruning [74]. During waking hours, encoding leads to
increased synaptic weights which eventually results in the saturation of synaptic networks. The
downscaling of certain synapses which takes place during stage N3 likely serves to ensure the
maintenance of balanced synaptic input. The negative correlations observed between stage N3
and memory in older adults, however, may reflect an altered balance between daytime encod-
ing and nighttime downscaling wherein older adults engage in less daytime encoding than
younger adults [75] but over-downscale if they are still gaining relatively high amounts of stage
N3. Thus, an age-related proportional increase in downscaling would presumably become det-
rimental to memory functioning if synapses that could otherwise help encode new memories
are pruned. Such sleep-dependent synaptic downscaling has been observed in Drosophila
[76,77].
Synaptic plasticity and scaling are crucial mechanisms in memory flexibility and AD onset
[73,78,79] with experimental downscaling of AMPA receptors contributing directly to AD
pathology [78]. In light of the genetic association data presented herein, it is possible that
APOE ε4/ε4 carriers are experiencing “overactive downscaling” [73]. APOE is produced by
the glia in the central nervous system [80], while APOE receptors are expressed on the neuro-
nal cell surface where they mediate lipoprotein uptake and signal transduction [81,82]. It has
been proposed that APOE isoforms may differentially accelerate synapse dysfunction and AD
APOE and slow wave sleep
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dementia by interfering with APOE receptor-dependent neuromodulation [81]. Of the three
APOE isoforms (ε2, ε3, and ε4), APOEε4 selectively impairs synaptic plasticity and NMDA
receptor phosphorylation by Reelin, a modulator of synaptic strength [79]. This selective
impairment of APOE receptor signaling by the APOEε4 isoform leads to a decrease in synaptic
responsiveness [79]. The APOEε4 isoform also reduces glutamate receptor function and syn-
aptic plasticity by selectively impairing APOE receptor recycling in primary neurons [79].
Sleep also impacts the cellular structure of the brain, including the ability of the brain to
clear beta-amyloid, contributing to synaptic degeneration and cognitive decline [34]. For
example, chronic sleep restriction increases amyloid-B plaque formation in the amyloid pre-
cursor protein transgenic mic [34]. Sleep also impacts the ability of the brain to remove poten-
tially toxic biomolecules that accumulate with normal neuronal function, including beta-
amyloid [34], which accumulates in APOEε4 genotype carriers [35]. This "glymphatic system"
is strongly stimulated by sleep and is associated with an increase in interstitial volume, possibly
by shrinkage of astroglial cells, leading to clearance activity. Clearance during sleep is as much
as two-fold faster than during waking hours [34]. Thus, glymphatic dysfunction may play a
role in the pathogenesis of neurodegeneration as well as maintenance of cognition. However,
it is also possible that accumulation of beta-amyloid and other toxic metabolites may influence
synaptic connectivity, and thus influence neurophysiological mechanisms of sleep, altering
sleep state distributions [83].
Few studies have examined the role of APOE genotype in both sleep and cognitive perfor-
mance [84,85]. In a study of 126 cognitively normal adults (30–70 years), chronic daytime
somnolence was associated with a distinctive decline in verbal memory among APOE ε4/ε4
carriers as compared to APOEε4 heterozygotes and noncarriers [84]. A second study examined
how sleep parameters in AD patients change over time as a function of APOEε4 status [85].
Among forty-four community-dwelling adults with a diagnosis of probable AD there was
greater deterioration on sleep parameters (increased WASO time and decreased TST and sleep
efficiency) in non-APOEε4 carriers when compared with positive APOEε4 carriers [85]. Asso-
ciations between sleep performance and cognition also differed between APOEε4 carriers and
non-carriers [85]. The APOEε4 allele has also been identified in studies as a risk factor for
sleep apnea, although the associations have not been consistent [43–51]. Despite these previous
APOEε4 -sleep associations, the APOEε4-stage N3 results reported herein were independent
of objective measures of sleep continuity as well as apnea hypopnea index.
In conclusion, these findings support a role for APOEε4 genotype in the regulation of stage
N3 in the elderly. Despite the established role of stage N3 in executive function [52,53] and
memory consolidation [54–57] in younger and middle-aged adults, the link between stage N3
and cognitive function may be weakened or changed in older adult population [73,86–89]
(including the MrOS study [72]). The negative correlations between stage N3 and subsequent
learning in older adults could involve several altered mechanisms [74,90] (including memory
consolidation, synaptic downscaling, or other macromolecular changes during stage N3 [83]).
As demonstrated in previous studies, increased stage N3 might predicts worse episodic mem-
ory consolidation in the elderly [88] and may be detrimental to morning recall [73,91–94].
Similar changes to the sleep–memory link have also been reported for old rodents [95,96]
showing that normal hippocampal reactivation is not preserved in older rats and that deep
sleep was associated with worse memory performance as measured by performance on the
Morris Water Maze task. Further research is needed to confirm the APOEε4- stage N3 associa-
tions and to identify the mechanism(s) by which APOEε4 alterations impact sleep architecture.
Quantitative EEG analysis will be useful also to elucidate whether APOE influences homeo-
static drive and sleep dynamics, and whether such changes associate with cognition. The
important strengths of this study are the large number of participants with overnight PSG,
APOE and slow wave sleep
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longitudinal cognitive function measures, and APOEε4 genotyping. An additional study
strength is the use of a large cohort of older adults who were not selected on the basis of sleep
or cognition characteristics. This study, however, was limited to white men and may not be
generalizable to other populations or women. If it is confirmed that increased total stage N3
time among APOE ε4/ε4 carriers reflects an overactive downscaling of synapses during sleep,
these results might in part explain the high risk of AD and age-related cognitive decline among
APOE ε4/ε4 carriers.
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